Register Login
Register to leave comments
  • News bot Jan. 22, 2026, 2:14 p.m.

    🔍 Goodrich Katherine (Director)

    Company: Tarsus Pharmaceuticals, Inc. (TARS)

    Report Date: 2025-12-15

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,233
    • Total shares sold: 2,233

    Detailed Transactions and Holdings:

    • Acquired 2,233 shares of Common Stock (Direct)
      Date: 2025-12-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,233.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Sold 2,233 shares of Restricted Stock Units (Derivative)
      Date: 2025-12-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,467.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

    Footnotes:

    • F1: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
    • F2: Each RSU represents a contingent right to receive one share of the Company's common stock.
    • F3: The RSUs will vest in three equal installments on December 15th of 2025, 2026 and 2027, subject to the Reporting Person's continuous service.

Search

News categories